The Cooper Companies, Inc. $COO Shares Sold by Magnetar Financial LLC

Key Points

• Magnetar Financial LLC significantly reduced its stake in The Cooper Companies by 94.3%, selling 668,063 shares, resulting in ownership of only 40,669 shares valued at approximately $3.43 million.
• Other large investors have also modified their stakes, with Goldman Sachs increasing its holdings by 17%, while SG Americas Securities increased its position by an astonishing 8,337%.
• The Cooper Companies reported earnings of $1.10 per share for the latest quarter, surpassing the consensus estimate, and its revenue saw a year-over-year increase of 5.7%.

Magnetar Financial LLC cut its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 94.3% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 40,669 shares of the medical device company's stock after selling 668,063 shares during the quarter. Magnetar Financial LLC's holdings in Cooper Companies were worth $3,430,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Zions Bancorporation National Association UT purchased a new position in Cooper Companies during the first quarter worth $33,000. City Holding Co. purchased a new position in Cooper Companies during the first quarter worth $34,000. GKV Capital Management Co. Inc. purchased a new position in Cooper Companies during the first quarter worth $40,000. Larson Financial Group LLC boosted its stake in Cooper Companies by 1,071.0% during the first quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock worth $61,000 after buying an additional 664 shares during the period. Finally, HM Payson & Co. boosted its stake in Cooper Companies by 147.4% during the first quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock worth $75,000 after buying an additional 532 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Up 2.7%

Shares of COO stock traded up $1.78 on Wednesday, hitting $67.11. The stock had a trading volume of 2,848,530 shares, compared to its average volume of 2,277,373. The company has a quick ratio of 1.23, a current ratio of 2.12 and a debt-to-equity ratio of 0.29. The business has a 50 day moving average price of $72.13 and a 200 day moving average price of $77.06. The company has a market cap of $13.34 billion, a PE ratio of 33.06, a P/E/G ratio of 1.63 and a beta of 0.97. The Cooper Companies, Inc. has a one year low of $61.78 and a one year high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.07 by $0.03. The firm had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The firm's quarterly revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.96 earnings per share. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Insider Activity

In related news, EVP Brian G. Andrews bought 1,525 shares of the business's stock in a transaction on Tuesday, September 2nd. The shares were bought at an average price of $65.68 per share, for a total transaction of $100,162.00. Following the completion of the purchase, the executive vice president directly owned 22,191 shares of the company's stock, valued at approximately $1,457,504.88. This trade represents a 7.38% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Daniel G. Mcbride bought 3,000 shares of the business's stock in a transaction on Tuesday, September 2nd. The stock was bought at an average price of $65.04 per share, for a total transaction of $195,120.00. Following the purchase, the chief operating officer directly owned 63,120 shares of the company's stock, valued at $4,105,324.80. The trade was a 4.99% increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.98% of the stock is owned by insiders.

Analyst Ratings Changes

Several research firms have commented on COO. Mizuho dropped their price objective on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating for the company in a research note on Wednesday, July 16th. Loop Capital set a $100.00 target price on Cooper Companies in a research report on Tuesday, June 17th. Needham & Company LLC reiterated a "buy" rating and set a $94.00 target price on shares of Cooper Companies in a research report on Thursday, August 28th. BNP Paribas upgraded Cooper Companies from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, July 22nd. Finally, Wells Fargo & Company decreased their target price on Cooper Companies from $93.00 to $72.00 and set an "overweight" rating for the company in a research report on Thursday, August 28th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $86.64.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.